Compounds useful as anti-inflammatory agents

Details Compounds useful as anti-inflammatory agents Compounds useful as anti-inflammatory agents

2007-07-10

2007-07-10

Habte, Kahsay (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S231500, C514S252030, C514S253010, C514S255050, C514S256000, C514S300000, C514S336000, C514S337000, C514S332000, C514S357000, C546S118000, C546S122000, C546S256000, C546S272700, C546S119000, C546S255000, C546S273400, C546S272400, C546S275400, C544S060000, C544S238000, C544S124000, C544S333000, C544S357000, C544S360000

Reexamination Certificate

active

10271301

ABSTRACT:
Disclosed are novel aromatic compounds of the formula (I) wherein G, X, Ar, L and Q are defined herein. The compounds are useful in pharmaceutic compositions for treating diseases or pathological conditions involving inflammation such as chronic inflammatory diseases. Also disclosed are processes of making such compounds

REFERENCES:
patent: 4435567 (1984-03-01), Lugosi et al.
patent: 4997844 (1991-03-01), Bernstein et al.
patent: 5162360 (1992-11-01), Creswell
patent: 5596001 (1997-01-01), Hamanaka
patent: 6166028 (2000-12-01), Bloom et al.
patent: 6319939 (2001-11-01), Mabire et al.
patent: 0 418 071 (1991-03-01), None
patent: 0 395 144 (1994-10-01), None
patent: WO 93/24458 (1993-12-01), None
patent: WO 94/18170 (1994-08-01), None
patent: WO 96/25157 (1996-08-01), None
patent: WO 96/39382 (1996-12-01), None
patent: WO 97/16442 (1997-05-01), None
patent: WO 98/5255 (1998-11-01), None
patent: WO 99/21835 (1999-05-01), None
patent: WO 99/23091 (1999-05-01), None
patent: WO 99/32106 (1999-07-01), None
patent: WO 99/32110 (1999-07-01), None
patent: WO 99/32111 (1999-07-01), None
patent: WO 99/32463 (1999-07-01), None
patent: WO 00/55139 (2000-09-01), None
patent: WO 00/55152 (2000-09-01), None
patent: US/00/31582 (2000-11-01), None
patent: WO 01/07403 (2001-02-01), None
Manuela G. Neuman, “Cytokines-central factors in alcoholic liver disease,” Winter 2003, Alcohol Research and Health, pp. 1-13.
Chalmers (TiPS vol. 17, pp. 166-172 Apr. 1996).
Mukhopadhyay et al. Respiratory Research 2006, 7:125 pp. 1-9.
http://www.permanente.net/homepage/kaiser/pages/f46315.html, downloaded on Nov. 13, 2006.
Lipton, James, M., Peptide Modulation of Inflammatory Processes within the Brain, Neuroimmunomodulation 1998: 5:178-183.
Li, Dayuan, Kinetics of tumor necrosis factor a in plasma and the cardioprotective effect of a monoclonal antibody to tumor necrosis factor a in acute myocardial infarction.; American Heart Journal, Jun. 1999; 1146-1152.
Raine, C.S., Multiple sclerosis: expression of molecules of the tumor necrosis factor ligand and receptor families in relationship to the demyelinated plaque. Rev Neurol (Paris) 1998; 8-9, 577-585.
Renzetti, L.M., Ro 45-2081, a TNF receptor fusion protein, prevents inflammatory responses in the airways.,Inflamm Res. 46, Supplement 2, {1997} S143-S144.
Viscardi, R.M., Inflammatory cytokine mRNAs in surgical specimens of necrotizing enterocolitis and normal newborn intestine., Pediatric Pathology & Laboratory Medicine, 17: 547-559, 1997.

Affiliated with

Also associated with

Rating

Compounds useful as anti-inflammatory agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds useful as anti-inflammatory agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds useful as anti-inflammatory agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3800215